Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
12/2021 ceased to operate
Musli Thyropeutics
Musli Thyropeutics Overview
Musli Thyropeutics offers a treatment that induces hypofunction of the thyroid gland in order to slow and inhibit cancer progression and enhance the efficacy of chemotherapy and radiotherapy. Current research is based on induction of hypothyroxinemia adjunct to conventional therapies in glioblastoma multiforme patients. The treatment's safety and efficacy are also being assessed, and the research is supported by the Tel Aviv Sourasky Medical Center.
Musli Thyropeutics Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Nov 14, 2016
clinicaltrials.gov
Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients - Full Text View - ClinicalTrials.gov